Effects of disease-modifying therapies on remyelination in multiple sclerosis; evaluation via visual evoked potential test.

Furkan SaridasFarid HojjatiShanay AlizadaSarra LazrakEmine Rabia KocOmer Faruk Turan
Published in: Multiple sclerosis and related disorders (2024)
Prolonged latency is associated with a long disease duration. Deterioration in both amplitude and latency is evident in high EDSS. These results may be an indirect consequence of axonal degeneration dominating remyelination. DMTs do not ameliorate impaired remyelination and neurodegeneration but seem to be sufficient for short-term maintenance of the current state.